NASDAQ: QNRXQuoin Pharmaceuticals Ltd Stock Ownership - Who owns Quoin Pharmaceuticals?
Insider buying vs selling
Have Quoin Pharmaceuticals Ltd insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Dennis Langer | Director | 2025-10-14 | 15,152 | $8.49 | $128.64kBuy |
| Denise P. Carter | Chief Operating Officer | 2024-12-23 | 555,556 | $0.45 | $250.00kBuy |
| Anthony James Culverwell | Director | 2024-12-23 | 100,000 | $0.45 | $45.00kBuy |
| Gordon Dunn | Chief Financial Officer | 2024-12-23 | 122,221 | $0.45 | $55.00kBuy |
| Michael Myers | Chief Executive Officer | 2024-12-23 | 555,556 | $0.45 | $250.00kBuy |
QNRX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when QNRX insiders and whales buy or sell their stock.
QNRX Shareholders
What type of owners hold Quoin Pharmaceuticals Ltd stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Michael Myers | 2.93% | 602,808 | $7.82M | Insider |
| Denise P. Carter | 2.93% | 602,648 | $7.82M | Insider |
| Gordon Dunn | 0.73% | 151,077 | $1.96M | Insider |
| Anthony James Culverwell | 0.49% | 100,317 | $1.30M | Insider |
| Dennis Langer | 0.07% | 15,153 | $196.69k | Insider |
| Rhumbline Advisers | 0.01% | 1,242 | $16.12k | Institution |
| Raymond James Financial Inc | 0.00% | 717 | $9.31k | Institution |
| Sally Bridget Lawlor | 0.00% | 440 | $5.71k | Insider |
| Gamma Investing LLC | 0.00% | 240 | $3.12k | Institution |
| Morgan Stanley | 0.00% | 206 | $2.67k | Institution |
QNRX vs Biotech Stocks
Quoin Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.